← Back to Clinical Trials
Recruiting NCT06192745

NCT06192745 SCREENS: Sleep, Circadian Rhythms, and Electronics in the EveNing Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06192745
Status Recruiting
Phase
Sponsor Baylor College of Medicine
Condition Sleep
Study Type INTERVENTIONAL
Enrollment 220 participants
Start Date 2025-01-10
Primary Completion 2028-08-30

Eligibility & Interventions

Sex All sexes
Min Age 8 Years
Max Age 11 Years
Study Type INTERVENTIONAL
Interventions
no screen control with dim light and calming activitiesunfiltered Bright tablet screenFiltered dim tablet screen

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 220 participants in total. It began in 2025-01-10 with a primary completion date of 2028-08-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The proposed project aims to disentangle the impact of evening light exposure emitted from tablet devices from the impact of arousing media content on children's sleep regulation, circadian physiology and next-day emotion regulation and executive functioning.

Eligibility Criteria

Inclusion Criteria: * children between 8.0 and 11.9 year old * Tanner stage 1 and 2 * live with their parent(s) (biological or legal guardian at least 50% of the time and has a primary role of caring for the child). * Children who sleep between 8.5 to 11 hours per night habitually * Children must sleep alone most nights * parent and child able to communicate and read and write in English * The child does not have to have access to a mobile device (tablet or Phone), but if they do, the primary device they use has to be an a) Android OS ≥5.0 either used only by the study child or shared with others, b) Amazon Fire OS ≥5.0 that only the child uses or c) an Apple iOS ≥14.0 that only the child uses. * If the child's primary device is a Android or Amazon Fired device, the parent and child agree to install Chronicle App (Android or Amazon). If the child's primary device is an Apple device, the parent and child agree to allow us to gather usage screenshots from the primary iPad or iPhone. * Families must live in the greater Houston area. Exclusion Criteria: * child blindness or colorblindness * significant vision problems * developmental or cognitive delays * diagnosis of a sleep or psychiatric disorder * diagnosed cognitive or learning impairment affecting executive functioning (e.g., attention deficit hyperactivity disorder) * medical conditions that impact sleep * taking medications that impact sleep * travel beyond 2 time zones in the month before starting the study

Contact & Investigator

Central Contact

Insia Raza, MPH

✉ insia.raza@bcm.edu

📞 713-798-0555

Principal Investigator

Jennette P Moreno, PhD

PRINCIPAL INVESTIGATOR

Baylor College of Medicine

Frequently Asked Questions

Who can join the NCT06192745 clinical trial?

This trial is open to participants of all sexes, aged 8 Years or older, up to 11 Years, studying Sleep. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06192745 currently recruiting?

Yes, NCT06192745 is actively recruiting participants. Contact the research team at insia.raza@bcm.edu for enrollment information.

Where is the NCT06192745 trial being conducted?

This trial is being conducted at Houston, United States.

Who is sponsoring the NCT06192745 clinical trial?

NCT06192745 is sponsored by Baylor College of Medicine. The principal investigator is Jennette P Moreno, PhD at Baylor College of Medicine. The trial plans to enroll 220 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology